Skip to main content
. Author manuscript; available in PMC: 2011 Aug 8.
Published in final edited form as: Eur J Pharmacol. 2009 Nov 18;628(1-3):187–194. doi: 10.1016/j.ejphar.2009.11.029

Fig. 4.

Fig. 4

IDRS is decreased by m-3M3FBS. Membrane potential was stepped from −80 to +40mV in 10mV increments from a holding potential of −80mV (A) in the presence of 4-AP (5mM, control) and (B) in the presence of m-3M3FBS (10μM) in 4-AP. (C) Normalized I-V relationships in control (○) and m-3M3FBS (●). Peak currents (I) were normalized with the peak current at +40mV (Imax). m-3M3FBS (10μM) significantly reduced IDRS (n=4, * denotes P<0.05 at −20mV). (D–F) o-3M3FBS also decreased IDRS (n=6, * denotes P<0.05 at −20mV). All tested potentials positive to −20mV were significant.